Engineered human stomach organoids, transplanted into mice, produced insulin-secreting cells, offering a potential new ...
Abzena and Mabqi bring together two organizations that are focused on advancing antibody innovation through integration.
Technology opens the door to more accurate preclinical testing, which could enable the development of safer and more effective therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback